GO Term | Evidence Code | PMID |
---|---|---|
toxin metabolic process | ||
positive regulation of apoptotic process | ||
nitric oxide biosynthetic process | ||
retinol metabolic process | ||
blood vessel endothelial cell migration |
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle | ||
endoplasmic reticulum membrane |
|
|
mitochondrion |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:11476 | osteoporosis | |
DOID:11541 | recurrent corneal erosion | |
DOID:11612 | polycystic ovary syndrome | |
DOID:1168 | familial hyperlipidemia | |
DOID:11714 | gestational diabetes | |
DOID:11847 | coronary thrombosis | |
DOID:11934 | head and neck cancer | |
DOID:11984 | hypertrophic cardiomyopathy | |
DOID:1227 | neutropenia | |
DOID:12270 | coloboma |
HPO ID | HPO Term |
---|---|
HP:0000593 | Abnormal anterior chamber morphology |
HP:0000603 | Central scotoma |
HP:0000639 | Nystagmus |
HP:0000659 | Peters anomaly |
HP:0001052 | Nevus flammeus |
HP:0001087 | Developmental glaucoma |
HP:0001138 | Optic neuropathy |
HP:0003593 | Infantile onset |
HP:0007759 | Opacification of the corneal stroma |
HP:0007854 | Glaucomatous visual field defect |
Disease ID | Disease Name |
---|---|
OMIM:617315 |
|
ORPHA:98976 |
|
OMIM:600975 |
|
ORPHA:98977 |
|
ORPHA:708 |
|
OMIM:231300 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
103178928 | CALMI16679 | ||
102362765 | LATCH13053 | ||
100150054 | ZFIN:ZDB-GENE-030902-1 | DANRE51342 | |
103036816 | ASTMX12103 | ||
100313516 | ICTPU26558 | ||
113579900 | ELEEL24477 | ||
106576803 | SALSA58343 | ||
106604807 | SALSA67237 | ||
115153034 | SALTR07184 | ||
115193979 | SALTR89651 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024